brexit - what next (da presentation) - steptoe & johnson€¦ · bpr authorisations and brexit...
TRANSCRIPT
Brexit - What next?
Internal Market Uncertainty - Defensive Strategies
Membership Meeting, BrusselsWednesday 23 November 2016
Darren Abrahams© Copyright 2016 Steptoe & Johnson LLP
www.steptoe.com 2
Defensive Strategies: Focus on REACH & Biocides
– Build (redundant) compliance models
– Check upstream supply chain undertakings
– Market Surveillance
– Issue Flagging
4
Current REACH Compliance Models: UK “OR”
5
http://www.nationsonline.org/oneworld/europe_map.htm
Importer (& Possibly Distributor)
Only Representative
Downstream User
Downstream User
Downstream User
Current REACH Compliance Models: UK Importer
6
http://www.nationsonline.org/oneworld/europe_map.htm
Distributor
Importer
Downstream User
Downstream User
Downstream User
Current REACH Compliance Models: UK Super Importer
7
http://www.nationsonline.org/oneworld/europe_map.htm
Distributor
“Super” Importer
Downstream User
Downstream User
Downstream User
Defensive Strategies
– Check upstream supply chain undertakings
Contractual compliance undertakings: Current non-EU manufacturers (OR’s) UK importers EU 27 importer undertakings Review/Amendment of Distribution Agreements
Fit for purpose, compliance with applicable law, bestefforts, indemnities etc.
8
Defensive Strategies
– Build (redundant) safeguard systems
OR transfers: Contractual transfer mechanism? Documented consent? New OR agreement? Define trigger event/mechanism REACH IT transfer & ECHA fee Formal notification of EU importers
Changing Physical Supply Route: Lean towards EU 27 ?
9
Defensive Strategies
– Market surveillance
Even if EU law applies in full up to BREXIT date: risk of free-riders? compliance drop-off post Article 50 notification? 31 May 2018 registration deadline (v. March 2017
+2 years Brexit window) companies ‘hedging bets’ re enforcement reduction of UK enforcement efforts?
Ensure your necessary compliance does notbecome a competitive disadvantage.
10
Defensive Strategies
– Issue flagging PPORD exemption if manufactured or imported in UK
– remainder of 5 years still applies?
Lead registrant and its joint registration status?– replacement? transitional arrangements?
Obligations on UK registrants:– pay for and provide further studies under substance
evaluation?
– SIEF mandatory data sharing – strategically draw outnegotiations…
– dossier compliance check draft decisions?– restrictions on placing on the market/uses, or under
authorisation?
11
BPR Article 95 list As of 1 Sept. 2015 those who (i) do not have access to a "complete
substance dossier" and (ii) therefore have not been included on the listof approved sources drawn up by ECHA by are excluded from themarket:
– Biocidal products "consisting of, containing or generating a relevantsubstance…shall not be made available [i.e. "any supply"] on the market orused unless either the substance supplier or the product supplier is included inthe list…for the product-type(s) to which the product belongs".
• "Substance supplier": "who manufactures [in EU] or imports [into EU] a relevantsubstance, on its own or in biocidal products" (No "Only Representative" role todisplace EU importer)
• "Product supplier": "who manufactures [in EU] or makes available on the market abiocidal product consisting of, containing or generating that relevant substance “
• Data Submitters: of a "complete dossier" under the Review Programme Regulation(Participants) or Supporters of New AS or "third party" AS dossiers submitted along witha Product authorisation, will also be included in list
www.steptoe.com 12
Current BPR Compliance Models: Art. 95 Representative
13
http://www.nationsonline.org/oneworld/europe_map.htm
Importer
EU Representative
Customers
CustomersCustomers
BPR authorisations and BREXIT
14www.steptoe.com
Move away from UK for “mutual recognition” of product authorisations
under the BPR?
www.steptoe.com 15
Darren Abrahams
English barrister, Avocat at the Brussels Bar, and Steptoe partner resident in Brussels
Focuses on EU regulatory requirements and the related commercial issues in the environment, chemicals, and life sciences areas. Works on: • Advocacy and representation before the CJEU, Board
of Appeal of ECHA, EU institutions and agencies, and national authorities
• Product defence and product approvals in the chemicals (REACH, CLP, biocides, agrochemicals, cosmetics) and biotechnology (genetically modified food, feed and plants) areas
• Due Diligence aspects of international transactions• Regulatory compliance programs and obtaining
licenses to operate • Commercial impacts of new EU regulatory initiatives,
and advocacy to help shape clients’ legislative and policy environment
16www.steptoe.com